Wed, February 26, 2020
Tue, February 25, 2020
Mon, February 24, 2020

Douglas Tsao Maintained (TBPH) at Strong Buy with Increased Target to $32 on, Feb 25th, 2020

Douglas Tsao of HC Wainwright & Co., Maintained "Theravance Biopharma, Inc." (TBPH) at Strong Buy with Increased Target from $30 to $32 on, Feb 25th, 2020.

Douglas, nor any peers, have made any analyst calls on TBPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30


Similar Stocks and Investing Publications